Nanosonics Limited (NNCSF)
USD 1.75
(0.0%)
USD 1.75
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 132.43 Million AUD | 5.39% |
| 2023 | 125.65 Million AUD | 45.86% |
| 2022 | 86.15 Million AUD | 15.01% |
| 2021 | 74.9 Million AUD | 5.36% |
| 2020 | 71.09 Million AUD | 13.65% |
| 2019 | 62.55 Million AUD | 38.27% |
| 2018 | 45.24 Million AUD | -9.8% |
| 2017 | 50.15 Million AUD | 55.93% |
| 2016 | 32.16 Million AUD | 115.86% |
| 2015 | 14.9 Million AUD | 11.33% |
| 2014 | 13.38 Million AUD | 61.77% |
| 2013 | 8.27 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 127.16 Million AUD | 1.2% |
| 2024 Q4 | 34.49 Million AUD | 0.0% |
| 2024 Q1 | 31.72 Million AUD | -53.06% |
| 2024 Q2 | 64.45 Million AUD | 103.19% |
| 2024 Q3 | 34.49 Million AUD | -46.48% |
| 2023 Q2 | 64.59 Million AUD | 100.72% |
| 2023 Q4 | 67.57 Million AUD | 103.9% |
| 2023 Q1 | 32.18 Million AUD | -30.37% |
| 2023 FY | 125.65 Million AUD | 45.86% |
| 2023 Q3 | 33.14 Million AUD | -48.69% |
| 2022 Q2 | 45.09 Million AUD | 94.37% |
| 2022 Q4 | 46.21 Million AUD | 103.14% |
| 2022 FY | 86.15 Million AUD | 15.01% |
| 2022 Q1 | 23.2 Million AUD | -48.32% |
| 2022 Q3 | 22.75 Million AUD | -49.55% |
| 2021 FY | 74.9 Million AUD | 5.36% |
| 2021 Q3 | 23.07 Million AUD | -32.62% |
| 2021 Q4 | 44.89 Million AUD | 94.59% |
| 2021 Q1 | 17.12 Million AUD | -56.23% |
| 2021 Q2 | 34.24 Million AUD | 100.0% |
| 2020 Q4 | 39.11 Million AUD | 100.0% |
| 2020 FY | 71.09 Million AUD | 13.65% |
| 2020 Q1 | 18.19 Million AUD | 12.92% |
| 2020 Q2 | 36.39 Million AUD | 100.0% |
| 2020 Q3 | 19.55 Million AUD | -46.27% |
| 2019 Q4 | 16.11 Million AUD | 0.0% |
| 2019 Q1 | 15.29 Million AUD | 33.21% |
| 2019 Q2 | 15.29 Million AUD | 0.0% |
| 2019 Q3 | 16.11 Million AUD | 5.4% |
| 2019 FY | 62.55 Million AUD | 38.27% |
| 2018 Q3 | 11.47 Million AUD | 2.79% |
| 2018 FY | 45.24 Million AUD | -9.8% |
| 2018 Q1 | 11.16 Million AUD | -6.38% |
| 2018 Q2 | 11.16 Million AUD | 0.0% |
| 2018 Q4 | 11.47 Million AUD | 0.0% |
| 2017 Q1 | 13.14 Million AUD | 34.63% |
| 2017 Q4 | 11.92 Million AUD | 0.0% |
| 2017 FY | 50.15 Million AUD | 55.93% |
| 2017 Q3 | 11.92 Million AUD | -9.28% |
| 2017 Q2 | 13.14 Million AUD | 0.0% |
| 2016 Q1 | 6.31 Million AUD | 120.45% |
| 2016 Q4 | 9.76 Million AUD | 0.0% |
| 2016 Q3 | 9.76 Million AUD | 54.64% |
| 2016 Q2 | 6.31 Million AUD | 0.0% |
| 2016 FY | 32.16 Million AUD | 115.86% |
| 2015 Q1 | 4.58 Million AUD | 23.93% |
| 2015 FY | 14.9 Million AUD | 11.33% |
| 2015 Q4 | 2.86 Million AUD | 0.0% |
| 2015 Q3 | 2.86 Million AUD | -37.52% |
| 2015 Q2 | 4.58 Million AUD | 0.0% |
| 2014 Q2 | 2.99 Million AUD | 0.0% |
| 2014 Q4 | 3.7 Million AUD | 0.0% |
| 2014 Q3 | 3.7 Million AUD | 23.64% |
| 2014 Q1 | 2.99 Million AUD | 13.01% |
| 2014 FY | 13.38 Million AUD | 61.77% |
| 2013 Q3 | 2.64 Million AUD | 77.84% |
| 2013 FY | 8.27 Million AUD | 0.0% |
| 2013 Q1 | 1.48 Million AUD | 0.0% |
| 2013 Q2 | 1.48 Million AUD | 0.0% |
| 2013 Q4 | 2.64 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -7694.506% |
| Ansell Limited | 624.8 Million USD | 78.803% |
| Ansell Limited | 624.8 Million USD | 78.803% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -16.232% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -97961.53% |
| Psykey, Inc. | 415.97 Thousand USD | -31737.654% |
| ConvaTec Group Plc | 1.2 Billion USD | 88.992% |
| ConvaTec Group Plc | 1.17 Billion USD | 88.727% |
| Encision Inc. | 3.13 Million USD | -4123.17% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -16579.45% |
| LifePoint, Inc. | -71.35 Thousand USD | 185695.168% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 101196.947% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -25126.095% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -21854.28% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -22105.288% |
| SmileDirectClub, Inc. | 275.84 Million USD | 51.989% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 85.297% |
| SheerVision, Inc. | 2.17 Million USD | -5986.514% |
| United Health Products, Inc. | -4857.00 USD | 2726824.315% |
| Vasamed, Inc. | -69.38 Thousand USD | 190964.415% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -49379.009% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -251432.705% |